XML 30 R14.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Measurements
 12 Months Ended
Sep. 28, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements FAIR VALUE MEASUREMENTS
Financial assets and liabilities — The following table presents the financial assets and liabilities measured at fair value on a recurring basis (in thousands):
TotalQuoted
Prices
in Active
Markets for
Identical
Assets (2)
(Level 1)		Significant
Other
Observable
Inputs (2)
(Level 2)		Significant
Unobservable
Inputs (2)
(Level 3)
Fair value measurements as of September 28, 2025:
Non-qualified deferred compensation plan (1)$18,326 $18,326 $— $— 
Total liabilities at fair value$18,326 $18,326 $— $— 
Fair value measurements as of September 29, 2024:
Non-qualified deferred compensation plan (1)$18,481 $18,481 $— $— 
Total liabilities at fair value$18,481 $18,481 $— $— 
________________________
(1)We maintain an unfunded defined contribution plan for key executives and other members of management. The fair value of this obligation is based on the closing market prices of the participants’ elected investments. The obligation is included in “Accrued liabilities” and “Other long-term liabilities” on our consolidated balance sheets.
(2)We did not have any transfers in or out of Level 1, 2, or 3.
The following table presents the carrying value and estimated fair value of our Class A-2 Notes as of September 28, 2025 and September 29, 2024 (in thousands):
September 28,
2025		September 29,
2024
Carrying AmountFair ValueCarrying AmountFair Value
Series 2019 Class A-2 Notes$692,375 $675,500 $699,625 $684,875 
Series 2022 Class A-2 Notes$1,023,000 $952,720 $1,045,000 $975,507 
The fair value of the Class A-2 Notes was estimated using Level 2 inputs based on quoted market prices in markets that are not considered active markets. As of September 28, 2025, we had no amounts outstanding under our Variable Funding Notes.
Non-financial assets and liabilities — Our non-financial instruments, which primarily consist of property and equipment, operating lease right-of-use assets, goodwill, and intangible assets, are reported at carrying value and are not required to be measured at fair value on a recurring basis. However, on an annual basis, or whenever events or changes in circumstances indicate that their carrying value may not be recoverable, non-financial instruments are assessed for impairment. If applicable, the carrying values are written down to fair value.
In connection with our impairment reviews performed during 2025 and 2024, the Company impaired certain assets. For further information, see Note 4, Summary of Refranchisings and Assets Held For Sale, Note 5, Goodwill and Intangible Assets, Net, and Note 9, Other Operating Expenses, Net in the notes to the consolidated financial statements.